By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Active Biotech AB 

Scheelevägen 22

Lund    SE-220 07  Sweden
Phone: 46-46-19-10-00 Fax: 46-46-19-20-50




Company News
Active Biotech (BTPC), NeoTX Ink $71 Million+ Immuno-Oncology Pact 10/26/2016 8:05:17 AM
FDA Takes Back Special Protocol Assessment for Active Biotech (BTPC)'s Laquinimod 9/19/2016 5:47:34 AM
Teva (TEVA), Active Biotech (BTPC) Stop Higher Doses of Laquinimod in Two Multiple Sclerosis Trials 1/4/2016 7:32:30 AM
Active Biotech (BTPC)'s Partner Teva (TEVA) Presents Data On Laquinimod For The Treatment Of Multiple Sclerosis At 31st ECTRIMS Congress 10/6/2015 8:00:35 AM
Teva (TEVA) And Active Biotech (BTPC) Announce Completion Of Patient Enrollment In Laquinimod Phase III CONCERTO Trial 6/25/2015 12:28:55 PM
Active Biotech (BTPC) Forced to Cut 47 of 56 Staffers After Phase III Prostate Cancer Failure 6/2/2015 7:11:58 AM
Teva (TEVA) And Active Biotech AB (BTPC) Announce First Patient Enrolled In Phase II Study Evaluating Laquinimod For Primary Progressive MS 4/23/2015 1:17:55 PM
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial 4/16/2015 10:23:37 AM
Teva Pharmaceutical Industries Limited (TEVA) And Active Biotech AB (BTPC) Announce Expansion Of Laquinimod Clinical Development Program With New Trial In Primary Progressive Multiple Sclerosis And First Patient Screened In Huntington’s Disease Trial 11/4/2014 10:29:23 AM
Active Biotech AB (BTPC) Presents Data On Paquinimod At EULAR 2014 6/11/2014 7:26:41 AM